Key result
CANRISK score performs comparably to FINDRISC for detecting prediabetes and undiagnosed diabetes.
Why the study?
Does the CANRISK score accurately estimate the risk of prediabetes and undiagnosed type 2 diabetes in Canadian adults?
Does the CANRISK score accurately estimate the risk of prediabetes and undiagnosed type 2 diabetes in Canadian adults?
The CANRISK score is a validated tool for estimating diabetes risk in Canadian adults to guide screening decisions.
The CANRISK score is a validated clinical tool for estimating the risk of prediabetes and undiagnosed type 2 diabetes in Canadian adults. It can be used to guide screening decisions but is not diagnostic. High and very high scores warrant HbA1c or other diagnostic testing for diabetes every 3-5 years or annually, respectively. The tool was developed and validated in Canadian cohorts, including multi-ethnic populations, and performs comparably to FINDRISC. Clinicians should apply judgment for high-risk features that are not captured by the CANRISK calculator.
No takes yet. Share an insight, caveat, or question.
Michelle D. Lundholm (2026) conducted a review in Prediabetes and undiagnosed type 2 diabetes. Canadian Diabetes Risk Assessment Questionnaire (CANRISK) vs. FINDRISC was evaluated. The CANRISK score performs comparably to FINDRISC for estimating the risk of prediabetes and undiagnosed type 2 diabetes in Canadian adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: